• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Geron Corp.

Pluristem launches Phase I clinical trial to treat tendonitis with stem cells

May 17, 2013 By Sony Salzman Leave a Comment

Pluristem Invasive Devices Inc. logo

Pluristem (NSDQ:PSTI) announced a new Phase I clinical trial to treat chronic tendonitis with the company’s PLX-PAD stem cell therapy.

Cell therapy has traditionally been used in cancer and cardiac treatments, but Pluristem is now applying the technology to sports-related injuries, where it has seen an increased interest among athletes and orthopedic surgeons.

Filed Under: News Well, Orthopedics, Stem Cells Tagged With: Aastron Biosciences, Clinical Trials, Geron Corp., InVivo Therapeutics, Pluristem, StemCells Inc.

Geron’s exit from stem cell business means opportunity for InVivo, others

November 16, 2011 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Aastrom Biosciences Inc, Amgen, Boston Scientific, Geron Corp., Imaging Diagnostic Systems, Intuitive Surgical, InVivo Therapeutics, INVO Bioscience, Pluristem, StemCells Inc., Steris Corp., Tengion Inc., The Cooper Cos., ThermoGenesis Corp.

First patient receives embryonic stem cells in spinal injury trial

October 12, 2010 By MassDevice staff Leave a Comment

stem cells

Physicians injected the first-ever patient with millions of stem cells derived from human embryos in a clinical trial aimed at proving the treatment is safe for people with spinal cord injuries.

The trial, sponsored by Geron Corp. (NSDQ:GERN), calls for patients to receive the injection within 14 days of the injury. Geron said the main objective of the study is to assess how well patients tolerate the treatment. Later phases of the trial will examine whether the treatment is effective, according to a press release.

Filed Under: Biotech, News Well, Stem Cells Tagged With: Geron Corp.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy